Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Association of the Social Vulnerability Index with Acuity of Presentation to Obstetric Triage.

American journal of perinatologyยท2026
Same author

Neonatal Inflammatory Profiles Associated With Perinatally Acquired Hepatitis C Viral Infection.

The Pediatric infectious disease journalยท2026
Same author

Predictors of Maternal Morbidity among Individuals at Low Risk of Postpartum Hemorrhage.

American journal of perinatologyยท2026
Same author

Early risk assessment and aspirin prophylaxis did not reduce preterm preeclampsia (letter to the editor).

American journal of obstetrics and gynecologyยท2026
Same author

Perinatal and Maternal Outcomes by Indication for Delivery in the Second Trimester.

American journal of perinatologyยท2026
Same author

Association of Intended Mode of Delivery With Neonatal and Maternal Outcomes at 22-25 Weeks of Gestation.

O&G openยท2026

Related Experiment Video

Updated: Jun 22, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Imitators of severe pre-eclampsia.

Baha M Sibai1

  • 1Department of Obstetrics and Gynecology, University of Cincinnati, College of Medicine, Cincinnati, OH 45267, USA. baha.sibai@uc.edu

Seminars in Perinatology
|May 26, 2009
PubMed
Summary
This summary is machine-generated.

Severe pre-eclampsia-eclampsia mimics are dangerous conditions that can occur during or after pregnancy. Accurate diagnosis is crucial for appropriate management and to prevent severe maternal and perinatal complications.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Related Experiment Videos

Last Updated: Jun 22, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Critical Care Medicine

Background:

  • Severe pre-eclampsia-eclampsia shares clinical and laboratory findings with various obstetric, medical, and surgical disorders.
  • These 'imitator' conditions are life-threatening emergencies with high maternal and perinatal mortality/morbidity.
  • Pathophysiologic similarities include vasospasm, platelet issues, microvascular thrombosis, endothelial dysfunction, and reduced perfusion.

Purpose of the Study:

  • To review the diagnosis, management, and counseling of rare conditions mimicking severe pre-eclampsia-eclampsia.
  • To highlight the importance of accurate differential diagnosis in obstetric emergencies.
  • To provide guidance based on recent studies and clinical experience.

Main Methods:

  • Literature review focusing on case reports and series of pre-eclampsia-eclampsia mimics.
  • Synthesis of findings on diagnosis and management strategies.
  • Incorporation of clinical experience in managing these rare syndromes.

Main Results:

  • Differential diagnosis is challenging due to overlapping clinical and laboratory features.
  • Conditions like acute fatty liver of pregnancy, TTP, HUS, SLE exacerbation, and sepsis syndromes are key mimics.
  • Accurate diagnosis is essential as management and complications differ significantly.

Conclusions:

  • Prompt and accurate diagnosis of pre-eclampsia-eclampsia mimics is critical for optimal patient outcomes.
  • Clinicians must be aware of these rare but severe conditions during pregnancy and postpartum.
  • Effective management requires a tailored approach based on the specific underlying disorder.